Fill out the form below for a free consultation


FDA asks for Blood Clot Warning for Testosterone Treatment

FDA asks for Blood Clot Warning for Testosterone Treatment

Monday, June 23rd, 2014

Last Friday, the FDA announced that labels for testosterone supplements must carry a warning of the risk of blood clots. The FDA said this risk is different from the current warning of the risk of blood clots linked to a condition known as polycythemia, which sometimes arises with testosterone treatment. This general blood clot risk is unrelated to that condition.

Blood clots are serious. Clots can be fatal when they travel to the lungs, which is known as a pulmonary embolism.

As a law team experienced with defective drug cases, we know how unexpected drug injuries can impact your life and the lives of your family members, resulting in consequences such as:

  • Lost wages
  • Current and ongoing medical bills
  • Pain and suffering

If you have suffered a serious injury while taking testosterone supplements or another medication, you may be able to pursue compensation in a defective drug claim handled by our lawyer.

This new warning comes on the heels of the announcement of an FDA investigation into claims of heart attack, stroke and death in men taking certain testosterone supplements. The FDA says Friday’s announcement and the ongoing investigation are unrelated.

If you or a loved one has been injured by a defective, dangerous drug, then please contact Charles N. Rock, PLLC, for a free case evaluation and to learn more about our experienced injury attorney serving New Paltz, New Windsor, Newburgh, Poughkeepsie, Kingston, Newburgh and the surrounding areas.
Category: Defective Drugs
Both comments and pings are currently closed.